Home >
NEWS
The review of Senova at the CPhI exhibition in Shanghai in 2019
2019 Shanghai CPhI exhibition had achieved successful results on June 20.Wonderful reviewSenova，a leading supplier for advanced intermediates in Generics field.During the exhibition, hundreds of customer representatives from home and abroad welcomed to..
2019-07-10
in-PHARMA JAPAN 2019
2019-07-05
The acquisition of FDA EIR certificate
Congratulations to our cooperative factory for obtaining the usFDA EIR with the support of the SENOVA’s registration team. As for us SENOVA , We are really proud of it.The acquisition of FDA EIR certificate means that the factory has risen to a new level o..
2019-06-28
The top 10 drug launches of 2019
Cancer is probably the most sought-after indication in the biopharma world, but it’s missing from 2019's class of top drug launches. Instead, treatments in immunology and rare genetic diseases have grabbed the limelight.We considered two EvaluatePharma pr..
2019-06-26
FDA accepts Celgene's ozanimod filing ahead of BMS close
Bristol-Myers Squibb scored more bragging rights for its coming megamerger: The FDA is now officially reviewing one of the "Big 5" Celgene candidates touted as cornerstones of the deal. And it's ozanimod, the blockbuster MS prospect whose applica..
2019-06-11
CPHI Shanghai 2019 invitation
CPHI Shanghai 2019 will be held from June 18 to 20, 2019.Our company's booth number is E6F10.Welcome to our company!
2019-05-24
Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: 309# in Building 3 of North Area, Dayuan Industry Park, Xili, Nanshan District of Shenzhen,China 518055 Tel: +86-0755-8670 3119 QQ: 530953397
Address: 309# in Building 3 of North Area, Dayuan Industry Park, Xili, Nanshan District of Shenzhen,China 518055 Tel: +86-0755-8670 3119 QQ: 530953397